ImageneBio CEO Kristin Yarema appointed interim principal financial officer

ImageneBio, Inc.

Board appointed CEO Kristin Yarema as interim CFO effective Oct 21, 2025.
Yarema previously served as CEO; biographical info referenced from Sept 2025 S-1 filing.
No reason for the change or prior CFO departure disclosed in the filing.
The appointment is effective immediately; Yarema continues as CEO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.